Farmakologian ja toksikologian laitos
Department of Pharmacology and Toxicology

Julkaisut 2008
Publications 2008

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Aaltonen N et al. Neuroanatomical mapping of juvenile rat brain regions with prominent basal signal in [35S]GTPgammaS autoradiography.
2 Annola K et al. Transplacental transfer of acrylamide and glycidamide are comparable to that of antipyrine in perfused human placenta.
3 Annola K et al. Simultaneous determination of acrylamide, its metabolite glycidamide and antipyrine in human placental perfusion fluid and placental tissue by liquid chromatography-electrospray tandem mass spectrometry.
4 Asikainen S et al. Functional characterization of endogenous siRNA target genes in Caenorhabditis elegans.
5 Girish CK et al. Effects of feedborne Fusarium mycotoxins on brain regional neurochemistry of turkeys.
6 Huttunen KM et al. Cytochrome P450-activated prodrugs: targeted drug delivery.
7 Huuskonen P et al. Microarray analysis of the global alterations in the gene expression in the placentas from cigarette-smoking mothers.
8 Kankkunen PM et al. A tale of two countries: comparison of the perceptions of analgesics among finnish and american parents.
9 Kemppainen T et al. Repeated early debridement does not provide significant symptomatic benefit after ESS.
10 Kumpulainen E et al. How readily does ketorolac penetrate cerebrospinal fluid in children?
11 Kääriäinen T. Interaction of the Dopaminergic and Serotonergic Systems in Rat Brain. Studies in Parkinsonian Models and Brain Microdialysis.
12 Kääriäinen TM et al. Serotonergic activation after 2-week intrastriatal infusion of L-dopa and slow recovery of circling in rats with unilateral nigral lesions.
13 Kääriäinen TM et al. Lack of robust protective effect of quercetin in two types of 6-hydroxydopamine-induced parkinsonian models in rats and dopaminergic cell cultures.
14 Lahtinen P et al. Remifentanil infusion does not induce opioid tolerance after cardiac surgery.
15 Laitinen K. Mitä psykoosilääkkeistä kysytään?
16 Laitinen K. Voiko lääke aiheuttaa peliriippuvuutta?
17 Laitinen K, Korhonen M. Mikä iäkkäiden lääkityksissä askarruttaa?
18 Malm H et al. Lääkkeet raskauden ja imetyksen aikana . "Skylla ja Kharybdis" (2. uudistettu p.).
19 Merlo DF et al. Scientific intergrity: critical issues in environmental health research.
20 Myllynen P et al. ABCG2/BCRP decreases the transfer of a food-born chemical carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhlP) in perfused term human placenta.
21 Myllynen PK et al. Kinetics of gold nanoparticles in the human placenta.
22 Myöhänen T. Distribution of Prolyl Oligopeptidase and its Colocalizations with Neurotransmitters and Substrates in Mammalian Tissues.
23 Myöhänen TT et al. Spatial association of prolyl oligopeptidase, inositol 1,4,5-triphosphate type 1 receptor, substance P and its neurokinin-1 receptor in the rat brain: an immunohistochemical colocalization stydy.
24 Myöhänen TT et al. Distribution of prolyl oligopeptidase in the mouse whole-body sections and peripheral tissues.
25 Myöhänen TT et al. Cellular and subcellular distribution of rat brain prolyl oligopeptidase and its association with specific neuronal neurotransmitters.
26 Määttä J. Cytokine, Chemokine, and Chemokine Receptor Expression in RAW 264.7 Mouse Macrophages and in the Lungs of Mice After Exposure to Wood Dust.
27 Mönkkönen K. Gai2 in Ciliated Tissues. Psysiological Role in Regulation of Ependymal Ciliary Function and Characteristics in Human Female Reproductive Tissues.
28 Pelkonen O et al. Inhibition and induction of human cytochrome P450 enzymes: current status.
29 Pietilä A-M, Halkoaho A. Terveyden edistämisen asiantuntijuus: preventiivisen hoitotieteen koulutus Kuopion yliopiston hoitotieteen laitoksella tukena matkalla asiantuntijaksi.
30 Pietilä A-M et al. Terveyden edistämisen tutkimuksen eettinen ja menetelmällinen perusta.
31 Pilvi TK et al. Effect of dietary calcium and dairy proteins on the adipose tissue gene expression profile in diet-induced obesity.
32 Puttonen KA et al. Different viabilities and toxicity types after 6-OHDA and Ara-C exposure evaluated by four assaays in five cell lines.
33 Rahnasto M et al. Identification of inhibitors of the nicotine metabolising CYP2A6 enzyme-an in silico approach.
34 Raunio H et al. Nicotine metabolism and urinary elimination in mouse: in vitro and in vivo.
35 Storvik M et al. Correlation between the SERT binding densities in hypothalamus and amygdala in Cloninger type 1 and 2 alcoholics.
36 Tacke U. Auttavatko masennuslääkkeet todella?
37 Tamminmäki A et al. Increase in free choice oral ethanol self-administration in Catechol-O-methyltransferase gene-disrupted male mice.
38 Tampio M et al. Benzo(a)pyrene increases phosphorylation of p53 at serine 392 in relation to p53 induction and cell death in MCF-7 cells.
39 Tupala E et al. Striatal dopaminergic terminals in type 1 and type 2 alcoholics measured with [3H]dihydrotetrabenazine and human whole himisphere autoradiography.
40 Vahtola E et al. Forkhead class O transcription factor 3a activation and Sirtuin1 overexpression in the hypertrophied myocardium of the diabetic Goto-Kakizaki rat.
41 Vähäkangas K. Molecular Epidemiology and Ethics: Biomarkers for Disease Susceptibility.
42 Vähäkangas K. Monitieteisen yhteistyön etiikka.
43 Vähäkangas KH et al. Globaali etiikka ja yliopiston tehtävät.
44 Warnakulasuriya S et al. Demonstration of ethanol-induced protein adducts in oral leukoplakia (pre-cancer) and cancer.
45 Westerén-Punnonen S et al. Somatosensory evoked potentials by median nerve stimulation in children during thiopental / sevoflurane anesthesia and the additive effects of ketoprofen and fentanyl.

Farmakologian ja toksikologian laitos Department of Pharmacology and Toxicology
Julkaisutietokanta 27.8.2009 Publications Data Base 27.8.2009